Article
Clinical validation of the Cervista HPV HR and 16/18 genotyping tests for use in women with ASC-US cytology.
Gynecologic oncology - 1 Aug 2010
Einstein Mark H, Martens Mark G, Garcia Francisco A R, Ferris Daron G, Mitchell Amy L, Day Stephen P, Olson Marilyn C
Abstract excerpt
OBJECTIVE: High-risk (HR) human papillomavirus (HPV) testing is important in cervical cancer screening for triage to colposcopy. This study evaluated the clinical performance of the Cervista HPV HR and 16/18 genotyping tests for detection of HPV in cervical cytology specimens. METHODS: The tests were prospectively evaluated in a multicenter clinical study. DNA was extracted from approximately 4000 residual...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
